Giora G. Z. Feuerstein

Giora G. Z. Feuerstein's AcademicInfluence.com Rankings

Philosophy

#3827

World Rank

#6120

Historical Rank

Logic

#1439

World Rank

#2190

Historical Rank

philosophy Degrees

Giora G. Z. Feuerstein

Biology

#4867

World Rank

#7206

Historical Rank

Neuroscience

#532

World Rank

#552

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Giora G. Z. Feuerstein's Degrees

Doctorate Medicine University of California, San Francisco
PhD Neuroscience University of California, San Francisco

Why Is Giora G. Z. Feuerstein Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Giora G. Z. Feuerstein's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations (2009) (1136)
Inflammatory Mediators and Stroke: New Opportunities for Novel Therapeutics (1999) (941)
Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. (1997) (859)
Tumor necrosis factor-alpha expression in ischemic neurons. (1994) (779)
Inflammation and Stroke: Putative Role for Cytokines, Adhesion Molecules and iNOS in Brain Response to Ischemia (2000) (651)
Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion. (1999) (523)
Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger. (1992) (511)
Cytokines, inflammation, and brain injury: role of tumor necrosis factor-alpha. (1994) (456)
Proteolytic Cascade Enzymes Increase in Focal Cerebral Ischemia in Rat (1996) (443)
Inhibition of extracellular signal-regulated kinase enhances Ischemia/Reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart. (2000) (439)
Ischemic preconditioning and brain tolerance: temporal histological and functional outcomes, protein synthesis requirement, and interleukin-1 receptor antagonist and early gene expression. (1998) (431)
The Role of Inflammation and Cytokines in Brain Injury (1996) (399)
Polymorphonuclear leukocyte infiltration into cerebral focal ischemic tissue: Myeloperoxidase activity assay and histologic verification (1991) (385)
IL-10 reduces rat brain injury following focal stroke (1998) (350)
Mouse Strain Differences in Susceptibility to Cerebral Ischemia are Related to Cerebral Vascular Anatomy (1993) (285)
Development of tissue damage, inflammation and resolution following stroke: An immunohistochemical and quantitative planimetric study (1993) (272)
Interleukin-8. A mitogen and chemoattractant for vascular smooth muscle cells. (1994) (269)
Caspase-8 and Caspase-3 Are Expressed by Different Populations of Cortical Neurons Undergoing Delayed Cell Death after Focal Stroke in the Rat (1999) (260)
Concomitant cortical expression of TNF-α and IL-1β mRNAs follows early response gene expression in transient focal ischemia (1994) (257)
Effects of factor IX or factor XI deficiency on ferric chloride‐induced carotid artery occlusion in mice (2005) (252)
Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol. (1998) (250)
Brain Cooling During Transient Focal Ischemia Provides Complete Neuroprotection (1997) (238)
The Role of Cytokines in the Neuropathology of Stroke and Neurotrauma (1998) (236)
Experimental brain injury induces differential expression of tumor necrosis factor-alpha mRNA in the CNS. (1996) (235)
2-Methoxyestradiol, an endogenous estrogen metabolite, induces apoptosis in endothelial cells and inhibits angiogenesis: possible role for stress-activated protein kinase signaling pathway and Fas expression. (1997) (219)
Experimental brain injury induces expression of interleukin-1 beta mRNA in the rat brain. (1995) (216)
Inflammatory Gene Expression in Cerebral Ischemia and Trauma (1997) (213)
A role for endogenous endothelin-1 in neointimal formation after rat carotid artery balloon angioplasty. Protective effects of the novel nonpeptide endothelin receptor antagonist SB 209670. (1994) (212)
Discovery of adrenomedullin in rat ischemic cortex and evidence for its role in exacerbating focal brain ischemic damage. (1995) (198)
Reperfusion Increases Neutrophils and Leukotriene B4 Receptor Binding in Rat Focal Ischemia (1992) (194)
Monocyte chemoattractant protein-1 messenger RNA expression in rat ischemic cortex. (1995) (193)
Neurohormonal activation, oxygen free radicals, and apoptosis in the pathogenesis of congestive heart failure. (1998) (192)
Expression of Interleukin-6, c-Fos, and zif268 mRNAs in Rat Ischemic Cortex (1995) (190)
Endothelin Levels Increase in Rat Focal and Global Ischemia (1994) (182)
Breathing 100% oxygen after global brain ischemia in Mongolian Gerbils results in increased lipid peroxidation and increased mortality. (1987) (179)
Staurosporine-induced apoptosis in cardiomyocytes: A potential role of caspase-3. (1998) (175)
Low dose intravenous minocycline is neuroprotective after middle cerebral artery occlusion-reperfusion in rats (2004) (173)
Carvedilol, a cardiovascular drug, prevents vascular smooth muscle cell proliferation, migration, and neointimal formation following vascular injury. (1993) (171)
Reperfusion following focal stroke hastens inflammation and resolution of ischemic injured tissue (1994) (170)
Delayed Expression of Osteopontin after Focal Stroke in the Rat (1998) (169)
Apoptosis in cardiac diseases: stress- and mitogen-activated signaling pathways. (2000) (165)
Interleukin-1β induces expression of adhesion molecules in human vascular smooth muscle cells and enhances adhesion of leukocytes to smooth muscle cells (1995) (165)
Interferon-inducible Protein-10 Involves Vascular Smooth Muscle Cell Migration, Proliferation, and Inflammatory Response* (1996) (163)
Osteopontin and its Integrin Receptor αvβ3 Are Upregulated During Formation of the Glial Scar After Focal Stroke (1998) (157)
Expression of endothelin-1, endothelin-3, endothelin-converting enzyme-1, and endothelin-A and endothelin-B receptor mRNA after angioplasty-induced neointimal formation in the rat. (1996) (156)
Benign focal ischemic preconditioning induces neuronal Hsp70 and prolonged astrogliosis with expression of Hsp27 (2000) (156)
Interleukin-1 receptor and receptor antagonist gene expression after focal stroke in rats. (1997) (154)
Platelet‐activating factor in stroke and brain injury (1991) (150)
Carvedilol, a novel multiple action antihypertensive agent with antioxidant activity and the potential for myocardial and vascular protection. (1995) (144)
Osteopontin-stimulated vascular smooth muscle cell migration is mediated by beta 3 integrin. (1994) (142)
Genetic hypertension and increased susceptibility to cerebral ischemia (1992) (140)
Upregulation of intercellular adhesion molecule 1 (ICAM-1) on brain microvascular endothelial cells in rat ischemic cortex. (1994) (134)
Opiate binding in rat hearts: modulation of binding after hemorrhagic shock. (1985) (128)
Optimal delivery of minocycline to the brain: implication for human studies of acute neuroprotection (2004) (126)
Adenosine triphosphate stimulates inositol phospholipid metabolism and prostacyclin formation in adrenal medullary endothelial cells by means of P2-purinergic receptors. (1987) (126)
Missing Steps in the STAIR Case: A Translational Medicine Perspective on the Development of NXY-059 for Treatment of Acute Ischemic Stroke (2008) (124)
Neuroprotective effects of phenyl-t-butyl-nitrone in gerbil global brain ischemia and in cultured rat cerebellar neurons (1992) (123)
Prolonged Expression of Interferon‐Inducible Protein‐10 in Ischemic Cortex After Permanent Occlusion of the Middle Cerebral Artery in Rat (1998) (122)
Novel mechanisms in the treatment of heart failure: inhibition of oxygen radicals and apoptosis by carvedilol. (1998) (118)
Cytokine-induced neutrophil chemoattractant mRNA expressed in cerebral ischemia (1993) (117)
Significant Neuroprotection against Ischemic Brain Injury by Inhibition of the MEK1 Protein Kinase in Mice: Exploration of Potential Mechanism Associated with Apoptosis (2003) (115)
Time-related changes in myeloperoxidase activity and leukotriene B4 receptor binding reflect leukocyte influx in cerebral focal stroke. (1995) (114)
Inhibition of sympathetic outflow by the angiotensin II receptor antagonist, eprosartan, but not by losartan, valsartan or irbesartan: relationship to differences in prejunctional angiotensin II receptor blockade. (1997) (113)
Induced expression of adhesion molecules following focal brain ischemia. (1995) (112)
Evidence for platelet-activating factor as a novel mediator in experimental stroke in rabbits. (1990) (111)
Prostaglandins, leukotrienes, and platelet-activating factor in shock. (1987) (110)
Coronary constriction by leukotriene C4, D4, and E4 in the intact pig heart. (1983) (110)
Carvedilol, a novel vasodilating beta-blocker with the potential for cardiovascular organ protection. (1996) (110)
Neuron-specific enolase increases in cerebral and systemic circulation following focal ischemia (1993) (108)
TL1, a Novel Tumor Necrosis Factor-like Cytokine, Induces Apoptosis in Endothelial Cells (1999) (106)
In Vivo Mononuclear Cell Tracking Using Superparamagnetic Particles of Iron Oxide: Feasibility and Safety in Humans (2012) (103)
Monocyte Chemoattractant Protein-1 is Upregulated in Rats With Volume-Overload Congestive Heart Failure (1999) (102)
Matrix Remodeling after Stroke: De Novo Expression of Matrix Proteins and Integrin Receptors (1999) (102)
Demonstration of increased endothelial-leukocyte adhesion molecule-1 mRNA expression in rat ischemic cortex. (1995) (102)
Neuroprotective Effects of Tetrodotoxin as a Na+ Channel Modulator and Glutamate Release Inhibitor in Cultured Rat Cerebellar Neurons and in Gerbil Global Brain Ischemia (1994) (101)
Lethal ischemia due to intracoronary endothelin in pigs. (1989) (99)
Leukotrienes and the cardiovascular system. (1984) (99)
Carvedilol, a new antihypertensive agent, prevents lipid peroxidation and oxidative injury to endothelial cells. (1993) (96)
Differential cardiovascular effects of μ, δ and κ opiate agonists at discrete hypothalamic sites in the anesthetized rat (1982) (95)
The development of stroke therapeutics: Promising mechanisms and translational challenges (2009) (95)
Carvedilol, a new beta-adrenoceptor antagonist and vasodilator antihypertensive drug, inhibits superoxide release from human neutrophils. (1992) (94)
Concomitant cortical expression of TNF-alpha and IL-1 beta mRNAs follows early response gene expression in transient focal ischemia. (1994) (94)
Production of Platelet‐Activating Factor from Rat Cerebellar Granule Cells in Culture (1990) (94)
Sputum matrix metalloproteinase-12 in patients with chronic obstructive pulmonary disease and asthma: relationship to disease severity. (2012) (93)
Inhibition of p 38 Mitogen-Activated Protein Kinase Decreases Cardiomyocyte Apoptosis and Improves Cardiac Function After Myocardial Ischemia and Reperfusion (1999) (92)
Assessment of arterial stiffness, a translational medicine biomarker system for evaluation of vascular risk. (2008) (91)
Mu-receptors mediate opioid cardiovascular effects at anterior hypothalamic sites through sympatho-adrenomedullary and parasympathetic pathways. (1983) (91)
Distribution of spin-trapping compounds in rat blood and brain: in vivo microdialysis determination. (1993) (91)
Leukotrienes in health and disease (1987) (90)
Prostacyclin reversal of lethal endotoxemia in dogs. (1981) (90)
Carvedilol, a new beta adrenoreceptor blocker and free radical scavenger, attenuates myocardial ischemia-reperfusion injury in hypercholesterolemic rabbits. (1996) (89)
Carvedilol, a new antihypertensive, prevents oxidation of human low density lipoprotein by macrophages and copper. (1992) (89)
Evidence for activation of endothelium and monocytes in hypertensive rats. (1996) (89)
Pharmacologic Interventions for Stroke: Looking Beyond the Thrombolysis Time Window Into the Penumbra With Biomarkers, Not a Stopwatch (2009) (87)
Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity. (1993) (87)
Pharmacology of Carvedilol: Rationale for Use in Hypertension, Coronary Artery Disease, and Congestive Heart Failure (1997) (86)
TRH: Cardiovascular and sympathetic modulation in brain nuclei of the rat (1983) (86)
Transforming growth factor-β1 exhibits delayed gene expression following focal cerebral ischemia (1995) (86)
Simvastatin and losartan enhance nitric oxide and reduce oxidative stress in salt-induced hypertension. (2005) (86)
Stroke risk factors prepare rat brainstem tissues for modified local Shwartzman reaction. (1988) (85)
Use of Suppression Subtractive Hybridization for Differential Gene Expression in Stroke: Discovery of CD44 Gene Expression and Localization in Permanent Focal Stroke in Rats (2001) (85)
Cardioprotective effects of carvedilol, a novel beta adrenoceptor antagonist with vasodilating properties, in anaesthetised minipigs: comparison with propranolol. (1992) (83)
Neuropeptide Y upregulates the adhesiveness of human endothelial cells for leukocytes. (1991) (82)
Postischemic production of eicosanoids in gerbil brain. (1987) (82)
Osteopontin and its integrin receptor alpha(v)beta3 are upregulated during formation of the glial scar after focal stroke. (1998) (81)
Neuroprotective Effects of Carvedilol, a New Antihypertensive Agent, in Cultured Rat Cerebellar Neurons and in Gerbil Global Brain Ischemia (1992) (80)
Blood Flow and Vascular Permeability During Motor Dysfunction in a Rabbit Model of Spinal Cord Ischemia (1992) (80)
Hypercholesterolemia impairs a detoxification mechanism against peroxynitrite and renders the vascular tissue more susceptible to oxidative injury. (1997) (79)
Effect of platelet-activating factor on coronary circulation of the domestic pig. (1984) (79)
μ Receptors and opioid cardiovascular effects in the NTS of rat (1982) (79)
Validation of laser-Doppler flowmetry in measurement of spinal cord blood flow. (1989) (78)
Interleukin-1 beta induces expression of adhesion molecules in human vascular smooth muscle cells and enhances adhesion of leukocytes to smooth muscle cells. (1995) (78)
Inhibition of Tumor Necrosis Factor-α-Converting Enzyme by a Selective Antagonist Protects Brain from Focal Ischemic Injury in Rats (2004) (77)
Application of real‐time polymerase chain reaction to quantitate induced expression of interleukin‐1β mRNA in ischemic brain tolerance (2000) (76)
Endothelin receptors: Receptor classification, novel receptor antagonists, and potential therapeutic targets (1996) (75)
The opioid system and central cardiovascular control: Analysis of controversies (1985) (75)
Release of Proinflammatory and Prothrombotic Mediators in the Brain and Peripheral Circulation in Spontaneously Hypertensive and Normotensive Wistar‐Kyoto Rats (1992) (74)
Antithrombotic efficacy of a novel murine antihuman factor IX antibody in rats. (1999) (73)
SB 211475, a metabolite of carvedilol, a novel antihypertensive agent, is a potent antioxidant. (1994) (72)
Carvedilol: A Novel Cardiovascular Drug with Multiple Actions (1992) (72)
Role of complement in endotoxin/platelet-activating factor-induced lung injury. (1992) (71)
Priming by platelet-activating factor of endotoxin-induced lung injury and cardiovascular shock. (1991) (70)
Carvedilol, a new vasodilating beta-adrenoceptor blocker, inhibits oxidation of low-density lipoproteins by vascular smooth muscle cells and prevents leukocyte adhesion to smooth muscle cells. (1995) (70)
Platelet-activating factor and progressive brain damage following focal brain injury. (1990) (69)
Carvedilol, a new beta-adrenoreceptor blocker antihypertensive drug, protects against free-radical-induced endothelial dysfunction. (1995) (69)
ARDS-like lung injury produced by endotoxin in platelet-activating factor-primed rats. (1993) (69)
Targeted Overexpression of Transmembrane Tumor Necrosis Factor Provokes a Concentric Cardiac Hypertrophic Phenotype (2003) (69)
CD44 deficiency in mice protects brain from cerebral ischemia injury (2002) (68)
Detection of Tumor Necrosis Factor-α mRNA Induction in Ischemic Brain Tolerance by Means of Real-Time Polymerase Chain Reaction (2000) (67)
Mitogen-activated Protein Kinase-activated Protein (MAPKAP) Kinase 2 Deficiency Protects Brain from Ischemic Injury in Mice* (2002) (67)
Carvedilol, a new vasodilating beta adrenoceptor blocker antihypertensive drug, protects endothelial cells from damage initiated by xanthine-xanthine oxidase and neutrophils. (1994) (67)
CGRP stimulates the adhesion of leukocytes to vascular endothelial cells (1992) (67)
Voltage-sensitive calcium flux into bovine chromaffin cells occurs through dihydropyridine-sensitive and dihydropyridine- and ω-conotoxin-insensitive pathways (1989) (66)
Deteriorating stroke model: histopathology, edema, and eicosanoid changes following spinal cord ischemia in rabbits. (1987) (66)
Protective effects of carvedilol in the myocardium. (1997) (66)
Hypothalamic sites for cardiovascular and sympathetic modulation by prostaglandin E2 (1982) (66)
Clinical validity of plasma and urinary desmosine as biomarkers for chronic obstructive pulmonary disease (2012) (65)
Cytokines in Brain Ischemia—The Role of TNFα (1998) (65)
Serum tumor necrosis factor-alpha profile in trauma patients. (1993) (64)
Alteration of leukotriene D4 hypotension by thyrotropin releasing hormone (1983) (64)
Central cardiovascular effects of vasotocin, oxytocin and vasopressin in conscious rats. (1984) (64)
Preferential secretion of adrenaline or noradrenaline by the cat adrenal in vivo in response to different stimuli (1971) (64)
The opioid peptides. A role in hypertension? (1987) (63)
Platelets stimulate expression of endothelin mRNA and endothelin biosynthesis in cultured endothelial cells. (1991) (63)
Platelet activating factor (PAF) and tumor necrosis factor-alpha (TNF alpha) interactions in endotoxemic shock: studies with BN 50739, a novel PAF antagonist. (1990) (62)
Effect of endothelin on cortical microvascular perfusion in rats. (1990) (62)
Carvedilol-liposome interaction: evidence for strong association with the hydrophobic region of the lipid bilayers. (1996) (62)
Autonomic pharmacology of leukotrienes. (1985) (62)
Vasopressin: An essential pressor factor for blood pressure recovery following hemorrhage (1982) (62)
Interleukin‐1β mRNA Expression in Ischemic Rat Cortex (1993) (62)
Subtractive cloning identifies tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) increased gene expression following focal stroke. (1998) (61)
Quantitative comparison of magnetic resonance imaging (MRI) and histologic analyses of focal ischemic damage in the rat (1991) (61)
The biochemical pharmacology of renin inhibitors: implications for translational medicine in hypertension, diabetic nephropathy and heart failure: expectations and reality. (2009) (61)
Cardiovascular and respiratory effects of mu-, delta- and kappa-opiate agonists microinjected into the anterior hypothalamic brain area of awake rats. (1983) (61)
Identification of endothelin receptors in various regions of rat brain (1990) (61)
The Endothelin Receptor Antagonist SB 217242 Reduces Cerebral Focal Ischemic Brain Injury (1995) (60)
Antioxidative enzymes in human hearts with idiopathic dilated cardiomyopathy. (2000) (60)
Effect of gram-negative endotoxin on levels of serum corticosterone, TNF alpha, circulating blood cells, and the survival of rats. (1990) (60)
Antagonism of neutrophil adherence in the deteriorating stroke model in rabbits. (1995) (60)
The opioid system in cardiac and vascular regulation of normal and hypertensive states. (1987) (59)
Lyophilized liposome encapsulated hemoglobin: Evaluation of hemodynamic, biochemical, and hematologic responses (1994) (58)
Lipopolysaccharide-induced production of tumor necrosis factor activity in rats with and without risk factors for stroke (1991) (57)
Carvedilol, A New Antihypertensive Drug with Unique Antioxidant Activity: Potential Role in Cerebroprotection (1994) (57)
Interleukin-8 is chemotactic for vascular smooth muscle cells. (1993) (56)
Comparison of metoprolol and carvedilol pharmacology and cardioprotection in rabbit ischemia and reperfusion model. (1998) (56)
Up-regulation of secretory leukocyte protease inhibitor (SLPI) in the brain after ischemic stroke: adenoviral expression of SLPI protects brain from ischemic injury. (2003) (55)
Methionine and leucine enkephalin in rat neurohypophysis: different responses to osmotic stimuli and T2 toxin. (1985) (55)
Cardiovascular, sympathetic, and renin-angiotensin system responses to hemorrhage in vasopressin-deficient rats. (1982) (55)
Characterization of hemodynamic, hematologic, and biochemical responses to administration of liposome-encapsulated hemoglobin in the conscious, freely moving rat. (1989) (54)
Differential cardiovascular effects mediated by mu and kappa opiate receptors in hindbrain nuclei (1983) (54)
Cardiovascular effects of rat calcitonin gene-related peptide in the conscious rat. (1988) (54)
δ versus μ receptors: cardiovascular and respiratory effects of opiate agonists microinjected into nucleus tractus solitarius of cats (1982) (53)
Nonpeptide endothelin receptor antagonists. II. Pharmacological characterization of SB 209670. (1994) (52)
Hypothalamic regulation of the cardiovascular and respiratory systems: role of specific opiate receptors (1983) (52)
Kappa opioid receptors modulate cardiorespiratory function in hindbrain nuclei of rat (1984) (51)
CARVEDILOL UPDATE IV : PREVENTION OF OXIDATIVE STRESS, CARDIAC REMODELING AND PROGRESSION OF CONGESTIVE HEART FAILURE (1997) (51)
Dehydroepiandrosterone protects mice inoculated with West Nile virus and exposed to cold stress (1992) (51)
Selective cardiorespiratory effects mediated by mu opioid receptors in the nucleus ambiguus (1984) (50)
Quantitation of Perivascular Monocytes and Macrophages around Cerebral Blood Vessels of Hypertensive and Aged Rats (1994) (50)
Carvedilol (Kredex) reduces infarct size in a canine model of acute myocardial infarction. (1991) (50)
Assessment of damage from implantation of microdialysis probes in the rat hippocampus with silver degeneration staining (1990) (49)
Hemodynamic and Neural Mechanisms of Action of Thyrotropin‐Releasing Hormone in the Rat (1988) (49)
Translational medicine for stroke drug discovery: the pharmaceutical industry perspective. (2009) (49)
A new salutary resuscitative fluid: liposome encapsulated hemoglobin/hypertonic saline solution. (1992) (49)
Effect of naloxone on the cardiovascular and sympathetic response to hypovolemic hypotension in the rat. (1981) (48)
An Inhibitory Anti-factor IX Antibody Effectively Reduces Thrombus Formation in a Rat Model of Venous Thrombosis (1999) (48)
SB 201823-A antagonizes calcium currents in central neurons and reduces the effects of focal ischemia in rats and mice. (1995) (47)
An improved clinically relevant sepsis model in the conscious rat (2000) (47)
Respiratory and locomotor stimulation by low doses of dermorphin, a mu1 receptor-mediated effect. (1990) (47)
Inhibition of tumor necrosis factor-alpha-converting enzyme by a selective antagonist protects brain from focal ischemic injury in rats. (2004) (46)
Chronic carvedilol reduces mortality and renal damage in hypertensive stroke-prone rats. (1996) (46)
Brain Injury and Inflammation. A Putative Role of TNFα (1995) (46)
Carvedilol prevents severe hypertensive cardiomyopathy and remodeling (1998) (46)
Mechanisms of hypotension produced by platelet-activating factor. (1989) (46)
Adrenalectomy blocks pressor responses to naloxone in endotoxic shock: evidence for sympathomedullary involvement. (1983) (46)
Effects of eprosartan on renal function and cardiac hypertrophy in rats with experimental heart failure. (1998) (45)
Opiate receptors and cardiovascular control in conscious SHR and WKY rats. (1983) (45)
Direct sequencing of DNA isolated from mRNA differential display. (1995) (45)
Locally Produced Tumor Necrosis Factor-α Mediates Interleukin-2Induced Lung Injury (1996) (44)
Increased Release of Tumor Necrosis Factor‐α Into the Cerebrospinal Fluid and Peripheral Circulation of Aged Rats (1993) (43)
Peptidic endothelin-1 receptor antagonist, BQ-123, and neuroprotection (1994) (43)
Neuroprotective Effects of SKF 10,047 in Cultured Rat Cerebellar Neurons and in Gerbil Global Brain Ischemia (1992) (43)
Dynorphins and leu-enkephalin in brain nuclei and pituitary of WKY and SHR rats (1983) (43)
Central cardiovascular effects of mammalian neurohypophyseal peptides in conscious rats (1983) (43)
Synergistic effect of liver X receptor activation and simvastatin on plaque regression and stabilization: an magnetic resonance imaging study in a model of advanced atherosclerosis. (2012) (42)
Comparing the antithrombotic efficacy of a humanized anti-factor IX(a) monoclonal antibody (SB 249417) to the low molecular weight heparin enoxaparin in a rat model of arterial thrombosis. (2000) (41)
Molecular cloning and expression of the rat monocyte chemotactic protein-3 gene: a possible role in stroke. (1999) (41)
Liposome encapsulation attenuates hemoglobin-induced vasoconstriction in rabbit arterial segments. (1997) (40)
Cardiac and coronary consequences of intracoronary platelet activating factor infusion in the domestic pig. (1987) (40)
Biological responses to liposome-encapsulated hemoglobin (LEH) are improved by a PAF antagonist. (1990) (39)
Expression of Interleukin-1β, Interleukin-1 Receptor, and Interleukin-1 Receptor Antagonist mRNA in Rat Carotid Artery after Balloon Angioplasty (2000) (39)
Carvedilol inhibits activation of stress-activated protein kinase and reduces reperfusion injury in perfused rabbit heart. (1998) (39)
Pharmacological profile of a novel neuronal calcium channel blocker includes reduced cerebral damage and neurological deficits in rat focal ischemia (1994) (39)
Platelet-activating factor (PAF) receptor-mediated calcium mobilization and phosphoinositide turnover in neurohybrid NG108-15 cells: studies with BN50739, a new PAF antagonist. (1991) (39)
Hypotension produced by platelet-activating factor is reversed by thyrotropin-releasing hormone. (1984) (38)
Role of immune and inflammatory mediators in CNS injury. (2000) (38)
Antagonism of dermorphin-induced catalepsy with naloxone, TRH-analog CG3703 and the benzodiazepine antagonist, Ro 15-1788 (1988) (38)
Cardiorespiratory, sympathetic and biochemical responses to T-2 toxin in the guinea pig and rat. (1985) (38)
Clinical perspectives of calcitonin gene related peptide pharmacology. (1995) (38)
Antihypertensive actions of the novel nonpeptide endothelin receptor antagonist SB 209670. (1995) (38)
Carvedilol, a new beta-adrenoreceptor blocker, vasodilator and free-radical scavenger, exerts an anti-shock and endothelial protective effect in rat splanchnic ischemia and reperfusion. (1995) (37)
Vascular effects of lipopolysaccharide are enhanced in interleukin-10-deficient mice. (1999) (37)
The sympathetic nervous system in man: its evaluation and the measurement of plasma NE (1984) (37)
Identification of endothelin receptors in cultured cerebellar neurons (1991) (37)
Characterization of platelet-activating factor-induced elevation of cytosolic free-calcium level in neurohybrid NCB-20 cells (1991) (36)
Distribution of immunoreactive dynorphin in discrete brain nuclei; comparison with vasopressin (1982) (36)
Effects of PAF and BN 52021 on cardiac function and regional blood flow in conscious rats. (1989) (36)
Cardiovascular effects of leukotriene D4 in SHR and WKY rats. (1981) (36)
Apoptosis and congestive heart failure. (1997) (35)
Recombinant adenoviral expression of dominant negative IκBα protects brain from cerebral ischemic injury (2002) (35)
Carvedilol update III: Rationale for use in congestive heart failure (1995) (35)
Platelet-activating factor. A putative mediator in central nervous system injury? (1990) (35)
Interleukin-1β (IL-1β) Induces Transforming Growth Factor-β1 (TGF-β1) Production by Rat Aortic Smooth Muscle Cells (1994) (35)
The use of antiserotonergic agents for the treatment of acute hemorrhagic shock of cats. (1985) (34)
Neuroprotective activities of carvedilol and a hydroxylated derivative: role of membrane biophysical interactions. (1998) (34)
Dopamine partially mediates the cardiovascular effects of naloxone after spinal injury (1981) (34)
Carvedilol prevents low-density lipoprotein (LDL)-enhanced monocyte adhesion to endothelial cells by inhibition of LDL oxidation. (1995) (34)
CHLAMYDIA INFECTION (2001) (34)
Biological responses to exchange transfusion with liposome-encapsulated hemoglobin. (1992) (34)
Cardiovascular effects of Dynorphin A-(1–8), Dynorphin A-(1–13) and Dynorphin A-(1–17) microinjected into the preoptic medialis nucleus of the rat (1984) (34)
Inflammatory Cells and Mediators in CNS Disease (2003) (34)
The influence of cold or isolation stress on resistance of mice to West Nile virus encephalitis (1990) (33)
Hemodynamic effects of endothelin after systemic and central nervous system administration in the conscious rat (1989) (33)
Protective effect of BN 50739, a new platelet-activating factor antagonist, in endotoxin-treated rabbits. (1990) (33)
Differential Regulation of IL-1β and TNF-α RNA Expression by MEK1 Inhibitor after Focal Cerebral Ischemia in Mice (2001) (33)
Anteroventral hypothalamus and hemorrhagic shock: cardiovascular and neuroendocrine responses. (1984) (33)
Cortical Microcirculation in a New Model of Focal Laser-Induced Secondary Brain Damage (1991) (33)
Aspiration-induced lung injury: role of complement. (1995) (33)
Evidence for an involvement of mu-, but not delta- or kappa-opiate receptors in sympathetically and parasympathetically mediated cardiovascular responses to opiates upon anterior hypothalamic injection. (1982) (32)
P‐selectin antagonism reduces thrombus formation in humans (2009) (32)
Platelet activating factor mediates interleukin-2-induced lung injury in the rat. (1992) (32)
Platelet-activating factor stimulates phosphoinositide turnover in neurohybrid NCB-20 cells: involvement of pertussis toxin-sensitive guanine nucleotide-binding proteins and inhibition by protein kinase C. (1992) (32)
Calcitonin gene-related peptide: a potent modulator of coronary flow. (1987) (32)
Cardiovascular responses to opioid agonists injected into the nucleus of tractus solitarius of anesthetized cats. (1982) (32)
Platelet-activating factor and cardiac diseases: therapeutic potential for PAF inhibitors. (1997) (32)
Thyrotropin-releasing hormone reverses experimental anaphylactic shock through non-endorphin-related mechanisms. (1983) (31)
Effect of indomethacin on the blood pressure and plasma catecholamine responses to acute endotoxaemia (1981) (30)
Liposome-encapsulated hemoglobin: an oxygen-carrying fluid. (1990) (30)
Dermorphin analog Tyr-D-Arg2-Phe-sarcosine-induced opioid analgesia and respiratory stimulation: the role of mu 1-receptors? (1993) (30)
Cardiovascular and sympathetic effects of l-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine in conscious SHR and WKY rats. (1982) (30)
Reversal by naloxone of hemorrhagic shock in anephric cats. (1980) (30)
Inflammation and stroke: benefits without harm? (2001) (29)
Effects of FPL-55712 or indomethacin on leukotriene-induced coronary constriction in the intact pig heart. (1983) (29)
Carvedilol: A Novel Multiple Action Antihypertensive Drug that Provides Major Organ Protection (1994) (29)
mu-Opioid receptors in NTS elicit pressor responses via sympathetic pathways. (1987) (29)
Pharmacologic profile of BN 50739, a new PAF antagonist in vitro and in vivo. (1990) (29)
Translational medicine--a paradigm shift in modern drug discovery and development: the role of biomarkers. (2009) (29)
Cognitive endpoints as disease biomarkers: optimizing the congruency of preclinical models to the clinic. (2008) (28)
Simultaneous changes of catecholamines and of Leu-enkephalin-like immunoreactivity in plasma and cerebrospinal fluid of cats undergoing acute hemorrhage (1984) (28)
Alteration in opiate receptors binding after hemorrhagic shock. (1984) (28)
Increased thromboxane A2 and 5-HETE production following spinal cord ischemia in the rabbit. (1987) (28)
Use of differential display to identify differentially expressed mRNAs induced by rat carotid artery balloon angioplasty. (1995) (28)
Role of chemokines in atherosclerosis. (1998) (28)
Transforming growth factor-beta 1 exhibits delayed gene expression following focal cerebral ischemia. (1995) (28)
Effect of endothelins on cytosolic free calcium concentration in neuroblastoma NG108-15 and NCB-20 cells (1990) (27)
Enhanced leucocyte adhesion to interleukin-1 beta stimulated vascular smooth muscle cells is mainly through intercellular adhesion molecule-1. (1994) (27)
Identification and characterization of calcitonin gene-related peptide receptors in porcine renal medullary membranes. (1991) (27)
Hemodynamic, hematologic and eicosanoid mediated mechanisms in 7.5 percent sodium chloride treatment of uncontrolled hemorrhagic shock. (1992) (27)
Thyrotropin‐Releasing Hormone Blocks the Hypotensive Effects of Platelet‐Activating Factor in the Unanesthetized Guinea Pig (1985) (27)
Use of Suppression Subtractive Hybridization Strategy for Discovery of Increased Tissue Inhibitor of Matrix Metalloproteinase-1 Gene Expression in Brain Ischemic Tolerance (1998) (26)
Carvedilol: preclinical profile and mechanisms of action in preventing the progression of congestive heart failure. (1998) (26)
Neuroprotective effects of carvedilol, a new antihypertensive, at the N-methyl-d-aspartate receptor (1992) (26)
Interleukin-2-induced lung injury. The role of complement. (1994) (26)
An increase in opiate receptor-sites is associated with enhanced cardiovascular depressant, but not respiratory depressant action of morphine (1984) (26)
Central effects of μ, δ, and κ receptor agonists in hemorrhagic shock (1985) (26)
Neuroprotective Mechanism of (+)SKF 10,047 In Vitro and in Gerbil Global Brain Ischemia (1992) (26)
Animal models of stroke. (2000) (25)
Characterisation and reproducibility of a human ex vivo model of thrombosis. (2010) (25)
Central autonomic effects of dermorphin in conscious rats. (1983) (25)
Protection by dehydroepiandrosterone in mice infected with viral encephalitis (2005) (25)
Comparative Analysis of Various Platelet Glycoprotein IIb/IIIa Antagonists on Shear-Induced Platelet Activation and Adhesion (2002) (25)
Control of bleeding is essential for a successful treatment of hemorrhagic shock with 7.5 per cent sodium chloride solution. (1991) (25)
Monoclonal antibodies to T-2 toxin. In vitro neutralization of protein synthesis inhibition and protection of rats against lethal toxemia. (1985) (25)
Inflammation and Stroke (2001) (25)
Antithrombotic Effects of a Platelet Fibrinogen Receptor Antagonist in a Canine Model of Carotid Artery Thrombosis (1992) (24)
Thyrotropin-releasing hormone reverses the hypotension and bradycardia produced by leukotriene D4 in unanesthetized guinea pigs. (1983) (24)
Effect of PAF on the Cardiovascular System (1987) (24)
Translational Medicine Lessons from Flurizan's Failure in Alzheimer's Disease (AD) Trial: Implication for Future Drug Discovery and Development for AD (2009) (24)
Cardiovascular effects of centrally administered vasopressin in conscious and anesthetized rats (1985) (24)
Adrenal catecholamine response to haemorrhage abolished by an angiotensin antagonist. (1977) (24)
The Janus face of inflammation in ischemic brain injury. (2004) (24)
Leukotriene D4: cardiovascular and sympathetic effects in spontaneously hypertensive rats (SHR) and Wistar-Kyoto (WKY) rats. (1982) (24)
Brain injury and inflammation. A putative role of TNF alpha. (1995) (24)
Endothelin receptor binding and cellular signal transduction in neurohybrid NG108-15 cells (1991) (24)
Effect of PSI‐697, a Novel P‐Selectin Inhibitor, on Platelet–Monocyte Aggregate Formation in Humans (2013) (24)
The effect of μ, δ, ϰ and ε opioid receptor agonists on heart rate and blood pressure of the pithed rat (1986) (24)
Effect of the small molecule plasminogen activator inhibitor‐1 (PAI‐1) inhibitor, PAI‐749, in clinical models of fibrinolysis (2010) (24)
Stoichiometric Quantification of Akt Phosphorylation Using LC-MS/MS (2009) (23)
The use of mRNA differential display for discovery of novel therapeutic targets in cardiovascular disease. (1997) (23)
Use of Diffusion-Weighted MRI and Neurological Deficit Scores to Demonstrate Beneficial Effects of Isradipine in a Rat Model of Focal Ischemia (1999) (23)
Excitatory amino acid neurotoxicity at the N-methyl-d-aspartate receptor in cultured neurons: protection by SKF 10,047 (1990) (23)
Laser-Doppler flowmetry in monitoring regulation of rapid microcirculatory changes in spinal cord. (1992) (23)
Endothelin and Heart Failure (2001) (23)
Inhibition of Factor Xa Reduces Ischemic Brain Damage After Thromboembolic Stroke in Rats (2003) (22)
Bombesin and substance P modulate peripheral sympathetic and cardiovascular activity (1985) (22)
Apoptosis—New Opportunities for Novel Therapeutics for Heart Diseases (2001) (22)
Hemoglobin-based oxygen-carrying resuscitation fluids. (1995) (22)
Apoptosis in Cardiac Diseases—New Opportunities for Novel Therapeutics for Heart Diseases (1999) (22)
Renin inhibitors: An antihypertensive strategy on the verge of reality (2005) (21)
Alteration of Cardiovascular, Neurogenic, and Humoral Responses to Acute Hypovolemic Hypotension by Administered Prostacyclin (1982) (21)
Neuroprotective effects of carvedilol, a new antihypertensive, as a Na+ channel modulator and glutamate transport inhibitor (1994) (21)
Increased cerebral lactate output to cerebral venous blood after forebrain ischemia in rats. (1990) (21)
Prominent white matter lesions develop in Mongolian gerbils treated with 100% normobaric oxygen after global brain ischemia (1990) (21)
Suppression subtractive hybridisation: application in the discovery of novel pharmacological targets. (2000) (21)
Expression of interleukin-1beta, interleukin-1 receptor, and interleukin-1 receptor antagonist mRNA in rat carotid artery after balloon angioplasty. (2000) (21)
Circulatory effects of PAF-acether in newborn piglets. (1989) (21)
Temporal Expression of ECE‐1, ET‐1, ET‐3, ETA, and ETB Receptor mRNAs After Balloon Angioplasty in the Rat (1995) (21)
Differential effect of fluorinated analogs of TRH on the cardiovascular system and prolactin release (1984) (21)
Recombinant adenoviral expression of dominant negative IkappaBalpha protects brain from cerebral ischemic injury. (2002) (21)
Platelet-activating factor: a putative neuromodulator and mediator in the pathophysiology of brain injury. (1994) (20)
Effect of naloxone and morphine on survival of conscious rats after hemorrhage. (1986) (20)
Effects of a hydroxylated metabolite of the β‐adrenoreceptor antagonist, carvedilol, on post‐ischaemic splanchnic tissue injury (1998) (20)
Evidence for differential opioid μ 1- and μ 2-receptor-mediated regulation of heart rate in the conscious rat (1992) (20)
Improved biological properties of synthetic distearoyl phosphatidyl choline-based liposome in the conscious rat. (1990) (20)
Pilot study on biocompatibility of fluorescent nanodiamond-(NV)-Z~800 particles in rats: safety, pharmacokinetics, and bio-distribution (part III) (2018) (20)
Catecholamines and vasopressin in forebrain nuclei of hypertension prone and resistant rats (1981) (20)
In vitro and in vivo properties of a fully human IgG1 monoclonal antibody that combats multidrug resistant Pseudomonas aeruginosa (2012) (20)
Cardioprotective potential of carvedilol. (1993) (20)
Catecholamines and vasopressin in hindbrain nuclei of hypertension prone and resistant rats (1982) (20)
CHAPTER 7 – Inflammatory Cytokines and Stroke: Emerging New Strategies for Stroke Therapeutics (1995) (20)
Modulation of U937 cell adhesion to vascular endothelial cells by cyclic AMP. (1991) (20)
SB 211475, a metabolite of carvedilol, reduces infarct size after myocardial ischemic and reperfusion injury in rabbits. (1998) (19)
Platelet‐Activating Factor: Diminished Acetylcholine Release from Rat Brain Slices Is Mediated by a Gi Protein (1994) (19)
The effect of indomethacin on isoprenaline-induced renin secretion in the cat. (1980) (19)
Tachykinin modulation of coronary blood flow. (1986) (19)
Coronary and pulmonary vascular effects of leukotrienes and PAF-acether. (1986) (19)
Extracellular catecholamine levels in rat hippocampus after a selective alpha-2 adrenoceptor antagonist or a selective dopamine uptake inhibitor: evidence for dopamine release from local dopaminergic nerve terminals. (1993) (19)
Platelet-activating factor and shock. (1988) (19)
Mob-1 expression in IL-2-induced ARDS: regulation by TNF-alpha. (1995) (19)
Locally produced tumor necrosis factor-alpha mediates interleukin-2-induced lung injury. (1996) (19)
The Effects of SB 206284A, a Novel Neuronal Calcium-Channel Antagonist, in Models of Cerebral Ischemia (1997) (19)
Norvaline2-TRH: binding to TRH receptors in rat brain homogenates. (1990) (19)
mRNA differential display: application in the discovery of novel pharmacological targets. (1996) (19)
The influence of cold or isolation stress on neuroinvasiveness and virulence of an attenuated variant of West Nile virus (2005) (19)
Unique coronary vasodilator induction by leukotriene D4. (1985) (18)
The Opioid System in Circulatory Control (1992) (18)
The Onset of Postischemic Hypoperfusion in Rats Is Precipitous and May Be Controlled by Local Neurons (1992) (18)
Systemic and regional hemodynamic effects of leukotrienes D4 and E4 in the conscious rat. (1986) (18)
Antioxidant Action of Carvedilol: A Potential Role in Treatment of Heart Failure (1999) (18)
Thromboxane and 5-HETE increase after experimental spinal cord injury in rabbits. (1987) (18)
Recent observations with β-adrenoceptor blockade : Beneficial effects in hypertension and heart failure (1996) (18)
Receptor binding of fluorinated histidine analogs of thyrotropin-releasing hormone in various regions of the rat brain. (1989) (18)
The Effect of Diet on Simvastatin and Losartan Enhancement of Endothelial Function (2007) (18)
Prostaglandins, catecholamines, and cardiovascular responses to hemorrhage. (1981) (18)
Leukotriene D4-induced hypotension is reversed by thyrotropin-releasing hormone. (1983) (17)
Translational stroke research in the developing brain. (2006) (17)
Cardiovascular effects of anatoxin-A in the conscious rat. (1990) (17)
Effect of dermorphin and morphine on the sympathetic and cardiovascular system of the pithed rat (1987) (17)
NPY family of peptides in neurobiology, cardiovascular and metalobic disorders : from genes to therapeutics (2006) (17)
The novel chemokine mob-1: involvement in adult respiratory distress syndrome. (1997) (17)
Calcium channel blockers in cerebral ischaemia. (1997) (17)
The NPY Family of Peptides in Immune Disorders, Inflammation, Angiogenesis and Cancer (2005) (17)
Integrated autonomic and behavioral responses to L/N Ca2(+)-channel blocker omega-conotoxin in conscious rats. (1990) (17)
Differential changes in substance P and somatostatin in brain nuclei of rats exposed to hemorrhagic shock (1984) (17)
Tumor necrosis factor-alpha mediates endotoxin-induced lung injury in platelet activating factor-primed rats. (1993) (16)
Pharmacogenomic, Physiological, and Biochemical Investigations on Safety and Efficacy Biomarkers Associated with the Peroxisome Proliferator-Activated Receptor-γ Activator Rosiglitazone in Rodents: A Translational Medicine Investigation (2010) (16)
Hemorrhagic shock and the central vasopressin and opioid peptide system of rats. (1985) (16)
Differential regulation of IL-1beta and TNF-alpha RNA expression by MEK1 inhibitor after focal cerebral ischemia in mice. (2001) (16)
Human transmissible spongiform encephalopathies. (1998) (16)
Mesenteric vascular responses to i.v. administration of lipoxin A4 and lipoxin B4 in the conscious rat (1988) (16)
Platelet-activating factor (PAF)--a putative mediator in inflammatory tissue injury. (1991) (16)
Antifibrillatory effects of BRL-32872 in anesthetized Yucatan minipigs with regional myocardial ischemia. (1995) (16)
Mechanisms of central hemodynamic and sympathetic regulation by mu opioid receptors: effects of dermorphin in the conscious rat. (1989) (16)
Respiratory μ-opioid and benzodiazepine interactions in the unrestrained rat (1993) (15)
Platelet-activating factor inhibits excitatory transmission in rat neostriatum (1993) (15)
Effects of Chronic Rosiglitazone Treatment on Renal Handling of Salt and Water in Rats With Volume-Overload Congestive Heart Failure (2011) (15)
Identification and characterization of triosephosphate isomerase that specifically interacts with the integrin αIIb cytoplasmic domain (2006) (15)
T-2 toxemia and brain prostaglandins. (1986) (15)
Effect of GABA agonist and antagonists on cardiovascular and sympathetic responses in SHR and WKY rats. (1981) (15)
Effect of thyrotropin releasing hormone and some of its histidine analogs on the cardiovascular system and prolactin release in the conscious rat (1986) (15)
Cardiac and vascular effects of leukotrienes. (1986) (14)
and Improves Cardiac Function After Myocardial Ischemia and Reperfusion Inhibition of p 38 Mitogen-Activated Protein Kinase Decreases Cardiomyocyte Apoptosis (1999) (14)
Central cardiovascular effects of prostacyclin (1981) (14)
Thyrotropin releasing hormone in hypovolemia: a hemodynamic evaluation in the rat. (1986) (14)
Effects of the novel antimigraine agent, frovatriptan, on coronary and cardiac function in dogs. (1998) (14)
Effect of PGD2, PGE2 PGF2 alpha and PGI on blood pressure, heart rate and plasma catecholamine responses to spinal cord stimulation in the rat. (1981) (14)
Vascular thrombus imaging in vivo via near-infrared fluorescent nanodiamond particles bioengineered with the disintegrin bitistatin (Part II) (2017) (13)
In vivo and ex vivo imaging of amyloid-β cascade aggregates with a Pronucleon™ peptide. (2013) (13)
Platelet-activating factor: a case for its role in CNS function and brain injury. (1996) (13)
Effects of coronary angioplasty on plasma platelet-activating factor in man. (1992) (12)
Bitistatin-functionalized fluorescent nanodiamond particles specifically bind to purified human platelet integrin receptor αIIbβ3 and activated platelets (2017) (12)
Effect of T-2 toxin on regional blood flow and vascular resistance in the conscious rat. (1986) (12)
Calcium Channel Blockers and Neuroprotection (1992) (12)
Effect of systemic platelet-activating factor (PAF) on the rabbit spinal cord microcirculation. (1990) (12)
Protective effect of a PAF-acether antagonist, BN 52021, in trichothecene toxicosis. (1987) (12)
THE MIXED LIPOXYGENASE/CYCLOOXYGENASE INHIBITOR SK&F 105809 REDUCES CEREBRAL EDEMA AFTER CLOSED HEAD INJURY IN RAT (1992) (12)
Differential cardiovascular effects of mu, delta and kappa opiate agonists at discrete hypothalamic sites in the anesthetized rat. (1982) (12)
Coronary restenosis : from genetics to therapeutics (1997) (12)
Use of differential display reverse transcription--polymerase chain reaction for discovery of induced adrenomedullin gene expression in focal stroke. (1997) (12)
Lyophilised reconstituted human platelets increase thrombus formation in a clinical ex vivo model of deep arterial injury (2012) (11)
Acute and chronic effects of eicosapentaenoic acid (EPA) on the cardiovascular system. (1989) (11)
Brain α-tocopherol levels are not altered following ischemia/reperfusion-induced cerebral injury in rats and gerbils (1993) (11)
Multimodal Magnetic Resonance Imaging for Assessing Evolution of Ischemic Penumbra: A Key Translational Medicine Strategy to Manage the Risk of Developing Novel Therapies for Acute Ischemic Stroke (2009) (11)
Agonist-stimulated release of von Willebrand factor and procoagulant factor VIII in rats with and without risk factors for stroke (1994) (11)
Drug receptors and control of the cardiovascular system: recent advances. (1991) (11)
Long-term biocompatibility of fluorescent diamonds-(NV)-Z~800 nm in rats: survival, morbidity, histopathology, particle distribution and excretion studies (part IV) (2019) (11)
Hypothalamic opioid μ-receptors regulate discrete hemodynamic functions in the conscious rat (1991) (11)
Hemodynamic defense response to thyrotropin-releasing hormone injected into medial preoptic nucleus in rats. (1991) (11)
Endogenous prostaglandins modulate adrenal catecholamine secretion. (1979) (11)
Using thrombelastography to determine the efficacy of the platelet glycoprotein IIb/IIIa antagonist, roxifiban, on platelet/fibrin-mediated clot dynamics in humans (2005) (11)
SB 209670 inhibits the arrhythmogenic actions of endothelin-1 in the anesthetized dog. (1998) (11)
Potential Early Predictors for Outcomes of Experimental Hemorrhagic Shock Induced by Uncontrolled Internal Bleeding in Rats (2013) (10)
5 LUNG-DERIVED TNFα TRIGGERS MULTI-CYTOKINE PRODUCTION IN ARDS (1995) (10)
The adrenergic system and the cardiovascular effects of platelet activating factor (1-0-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine) in SHR and WKY rats. (1985) (10)
Eicosanoids in Deteriorating Stroke: Review of Studies on the Rabbit Spinal Cord Ischemia and Reperfusion Model a , b (1989) (10)
Effects of platelet-activating factor on coronary hemodynamics and coronary venous plasma levels of TXB2, 6-keto-PGF1 alpha, and leukotriene C4 immunoreactivity in the intact domestic pig heart. (1985) (10)
Inflammation and stroke: therapeutic effects of adenoviral expression of secretory Leukocyte Protease Inhibitor. (2006) (10)
RENIN‐ANGIOTENSIN MEDIATION OF ADRENAL CATECHOLAMINE SECRETION INDUCED BY HYPOGLYCAEMIA IN THE CAT (1980) (10)
Overall and regional hemodynamic effects of leukotriene D4 in spontaneously hypertensive rats. (1985) (10)
Interleukin-1 beta (IL-1 beta) induces transforming growth factor-beta, (TGF-beta 1) production by rat aortic smooth muscle cells. (1994) (10)
Cardiovascular and sympathetic responses to PGF2α injection into hypothalamic nuclei (1981) (10)
Differential hemodynamic effects of leukotriene D4 in anesthetized rats: evaluation by directional pulsed Doppler technique. (1985) (10)
Increased 5‐HETE Production in the Brain following Head Injury (1989) (10)
Early Gene Expression Outcomes , Protein Synthesis Requirement , and Interleukin-1 Receptor Antagonist and Ischemic Preconditioning and Brain Tolerance : Temporal Histological and Functional (1998) (10)
Motilin effects on the heart and blood vessels of the pithed rat (1985) (10)
Selective hippocampal lesion following ω-conotoxin administration in rats (1990) (10)
Effect of idomethacin on cardiac β-adrenergic receptors (1980) (10)
Cloning and expression of rat coagulation factor VII. (2003) (10)
Inverse relationship of medulla oblongata noradrenaline concentration and tyrosine hydroxylase activity in hypertension‐prone and ‐resistant rats 1 (1979) (10)
N-acetyl-leukotriene E4 is a potent constrictor of rat mesenteric vessels. (1988) (10)
Modification by SQ 14225 of blood pressure and adrenal catecholamine response to hemorrhage. (1979) (9)
Inflammation and Cardiac Diseases (2003) (9)
Beta-blockers in congestive heart failure: the pharmacology of carvedilol, a vasodilating beta-blocker and antioxidant, and its therapeutic utility in congestive heart failure. (1998) (9)
Reversal of leukotriene D4 hypotension by thyrotropin-releasing hormone (1984) (9)
The effect of saline loading on blood pressure and catecholamine secretion in the rat and the cat. (1979) (9)
EFFECT OF LIPOSOME‐ENCAPSULATED HEMOGLOBIN ON THE DEVELOPMENT OF ENDOTOXIN‐INDUCED SHOCK IN THE RAT (1998) (9)
Monoclonal antibodies against the presynaptic calcium channel antagonist ω‐conotoxin GVI A from cone snail poison (1990) (9)
Cardiac RAGE in sepsis: call TOLL free for anti-RAGE. (2008) (9)
Biomarkers in the development of novel disease-modifying therapies for osteoarthritis. (2008) (9)
A goldfish model for evaluation of the neurotoxicity of omega-conotoxin GVI A and screening of monoclonal antibodies. (1991) (9)
Multimodal Biomarker Investigation on Efficacy and Mechanism of Action for the Mammalian Target of Rapamycin Inhibitor, Temsirolimus, in a Preclinical Mammary Carcinoma OncoMouse Model: A Translational Medicine Study in Support for Early Clinical Development (2011) (9)
Carvedilol case history: the discovery and development of the first β-blocker for the treatment of congestive heart failure (2006) (9)
Mechanisms involved in central cardiovascular effects of prostaglandin F2 alpha. (1982) (8)
Dissociation of the cardiovascular and prolactin-releasing activities of norvaline2-TRH (1987) (8)
Leukotrienes and shock. (1985) (8)
Biocompatibility studies of fluorescent diamond particles-(NV)~800nm (part V): in vitro kinetics and in vivo localization in rat liver following long-term exposure (2019) (8)
Selective cardiorespiratory activity of an iodinated analog of thyrotropin-releasing hormone (TRH) (1990) (8)
Volume-dependent spatial distribution of microinjected thyrotropin-releasing hormone (TRH) into the medial preoptic nucleus of the rat: An autoradiographic study (1990) (8)
Position Paper: The Sympathetic Nervous System and Hypertension (1981) (8)
Cardiovascular and sympathetic responses to chronic arachidonate in SHR and WKY rats. (1983) (8)
Inhibition of eicosanoid‐mediated coronary constriction during myocardial ischemia 1 (1988) (8)
Tumor Necrosis Factor‐&agr; Expression in Ischemic Neurons (1994) (8)
Identification and characterization of triosephosphate isomerase that specifically interacts with the integrin alphaIIb cytoplasmic domain. (2006) (8)
Hypothalamic mu-opioid receptors in cardiovascular control: A review (1988) (8)
Selective reduction of adrenal medulla response to angiotensin induced by suppression of renin-angiotensin. (1979) (8)
Carvedilol inhibits aortic lipid deposition in the hypercholesterolemic rat. (1997) (8)
Comparison of endothelin binding and calcium mobilization in C6-BU-1 rat glioma and N18TG2 mouse neuroblastoma cells (1991) (8)
Central ventilatory effects of thyrotropin-releasing hormone in the conscious rat (1991) (7)
Central Autonomic Pharmacology of Thyrotropin Releasing Hormone (1987) (7)
Receptor binding and biological activity of the dermorphin analog Tyr-D-Arg(2)-Phe-Sar (TAPS). (2001) (7)
Current understanding of sepsis: criticism and a proposal (1995) (7)
The supraoptic nuclei in vasopressin and hemodynamic responses to hemorrhage in rats. (1991) (7)
Importance of interleukin‐8 and chemokines in organ injury and shock (1994) (7)
Inhibitory effect of new PAF antagonists on PAF-induced rabbit platelet aggregation in vitro and ex vivo. (1991) (6)
Differential effect of the GPIIb/IIIa antagonist orbofiban on human platelet aggregate formation in vitro. (2003) (6)
Effects of nafazatrom on cardiovascular, sympathetic, and endocrine responses to hemorrhagic shock in conscious rats. (1985) (6)
Leukotriene D4 inhibits cardiovascular responses to sympathetic stimulation, angiotensin and vasopressin in the pithed spontaneously hypertensive rats. (1984) (6)
Vasoactive Mediators of Cerebral Vessels (1997) (6)
Generation, validation and humanisation of a novel insulin resistant cell model. (2010) (6)
PAF and TNFα Interactions in the Pathophysiology of Septic Shock (1991) (6)
Inflammation — A new frontier in cardiac disease and therapeutics (2003) (6)
Effects of calcium entry blockers on coronary constriction and myocardial ischemia due to leukotriene D4. (1985) (6)
Use of novel downstream primers for differential display RT-PCR. (1998) (6)
Therapeutic Effect of Dexamethasone in T-2 Toxicosis (1987) (6)
Recent observations with beta-adrenoceptor blockade. Beneficial effects in hypertension and heart failure. (1998) (5)
Platelet-Activating Factor as a Modulator of Cardiac and Coronary Functions (1985) (5)
Effect of indomethacin on blood pressure, catecholamine, and renin response to acute hemorrhage. (1980) (5)
Cardiovascular effects of platelet-activating factor (1991) (5)
Chemokines and ischemic stroke (2001) (5)
G proteins and heart failure (1990) (5)
Cardiovascular & Renal: Clopidogrel: A Novel Antiplatelet Drug for Prevention and Treatment of Thrombotic Disorders (1995) (5)
Delta versus mu receptors: cardiovascular and respiratory effects of opiate agonists microinjected into nucleus tractus solitarius of cats. (1982) (5)
Cytokine Gene and Peptide Regulation in Lung Microvascular Injury: New Insights on the Development of Adult Respiratory Distress Syndrome (1994) (5)
The Adrenergic Pharmacology of Carvedilol (1999) (5)
Platelet-activating factor (PAF) has no direct effect on rat intracerebral arterioles in vitro. (1991) (5)
Attenuation of the lithium-induced diabetes-insipidus-like syndrome by amiloride in rats. (1981) (5)
Reversal of intracellular toxicity of the trichothecene mycotoxin T-2 with monoclonal antibody. (1990) (5)
Interaction of thyrotropin-releasing hormone (TRH) and serotonin in cardiovascular control. (1988) (5)
The coagulation factor lottery – Is 9 the winning number?: An essay on future oral anticoagulants (2005) (5)
Substance K: Vascular and cardiac effects in rat and pig (1985) (5)
Comparison of stimulated tissue factor expression by brain microvascular endothelial cells from normotensive (WKY) and hypertensive (SHR) rats (1992) (4)
Effect of morphine on the hemodynamic and neuroendocrine responses to hemorrhage in conscious rats. (1989) (4)
Effects of chronic arachidonate on blood pressure of spontaneously hypertensive rats. (1983) (4)
The Use of Near-Infrared Light-Emitting Fluorescent Nanodiamond Particles to Detect Ebola Virus Glycoprotein: Technology Development and Proof of Principle (2020) (4)
Binding of the nonpeptide antagonist, SB 209670, to endothelin receptors on cultured neurons (1995) (4)
Effects of the glycoprotein IIb/IIIa antagonist Roxifiban on P-selectin expression, fibrinogen binding, and microaggregate formation in a phase I dose-finding study: no evidence for platelet activation during treatment with a glycoprotein IIb/IIIa antagonist (2003) (4)
Effect of hemorrhage on vasopressin, dynorphin A, and leu5-enkephalin in the hypothalamo-pituitary system of the rat. (1984) (4)
Effect of indomethacin on water intake of the rat (1978) (4)
Summary: Immune and inflammatory modulators as potential therapeutic targets for cardiac diseases (2003) (4)
REVERSAL OF PROSTAGLANDIN E2 EFFECT ON ADRENAL CATECHOLAMINE RELEASE AFTER HYPOPHYSECTOMY (1977) (4)
Neuropeptide Y and the heart: implication for myocardial infarction and heart failure. (2006) (4)
Translational Medicine—a Paradigm Shift in Modern Drug Discovery and Development: The Role of Biomarkers (2010) (4)
The role of IL-6 and related cytokines in myocardial remodeling and inflammation – implication for cardiac hypertrophy and heart failure (2003) (4)
Angiotensin II mediation of adrenal catecholamine secretion induced by intrarenal isoprenaline infusion. (1978) (4)
Central Catecholamine Systems: Interaction with Neurotransmitters in Normal Subjects and in Patients with Selected Neurologic Diseases (1985) (4)
G proteins and heart failure: is Galphaq a novel target for heart failure? (2000) (4)
Lithium-induced increase in the metabolism of benzo[a]pyrene and drugs in rat liver. (1979) (3)
Platelet-activating factor in cardiovascular stress situations (1991) (3)
Leukotriene D4 and hypoxia: differential effects on the pulmonary and systemic circulations in newborn piglets. (1989) (3)
Effects of prolonged lithium treatment on the water consumption and lithium content of rats. (1979) (3)
Central effects of mu, delta, and kappa receptor agonists in hemorrhagic shock. (1985) (3)
The effect of angiotensin II on in vitro prolactin and LH release from the rat pituitary (1979) (3)
Cardiac Remodeling: From Concepts to Therapeutics (1999) (3)
Drug Evaluation Cardiovascular & Renal: Carvedilol: a new paradigm for the treatment of congestive heart failure (1996) (3)
Effects of orally active glycoprotein IIb/IIIa antagonists on platelet CD40 ligand (CD154) expression and platelet-heteroaggregate formation. (2002) (3)
The effect of mu, delta, kappa and epsilon opioid receptor agonists on heart rate and blood pressure of the pithed rat. (1986) (3)
Discontinued drugs in 2006: cardiovascular drugs translational medicine perspective (2007) (3)
Characterization of CGRP receptors in various regions of gerbil brain (1994) (3)
Dermorphin: cardiovascular and sympathetic modulation in the anteroventral hypothalamus of conscious rats. (1983) (3)
Inflammatory Mediators in Brain Microvessels (1997) (3)
The antiplatelet GPIIb/IIIa antibody, 7E3: A pioneer drug for the treatment of arterial thrombotic disorders (1994) (3)
Rosiglitazone treatment restores renal responsiveness to atrial natriuretic peptide in rats with congestive heart failure (2019) (3)
Long-Term Sampling of Cerebral Venous Blood in Conscious Rats (1989) (3)
In Vivo Enhancement of Platelet Activating Factor‐Induced Prostacyclin Production by OKY‐046, a Selective Inhibitor of Thromboxane A2 Synthase (1991) (3)
L‐649,923: An Antagonist of Cardiac and Vascular Leukotriene D4 Receptors (1989) (2)
SB211475 EXERTS MORE POTENT PROTECTION IN RAT SPLANCHNIC ISCHEMIA‐REPERFUSION INJURY THAN ITS PARENT COMPOUND CARVEDILOL.: 7 (1996) (2)
Pharmacological profile of G619, a new platelet aggregation inhibitor. (1992) (2)
Imaging Biomarkers for Diagnosis, Prognosis and Treatment of Alzheimer's Disease (2012) (2)
Direct sequencing of differential display PCR products. (1997) (2)
Characterization of binding kinetics of [3H]Tyr-D-Arg2-Phe-Sar4 at opioid receptors. (2003) (2)
Peroxisome Proliferator-Activated Receptor Alpha and Alpha/Gamma Agonists Do Not Cause Impairment in Renal Function in the Rat (2010) (2)
Homologous desensitization of calcitonin gene-related peptide response in rat glomerular mesangial cells in culture (1992) (2)
Coronary Leukotriene Levels and Myocardial Ischemia (1985) (2)
New opportunities for stroke prevention and therapeutics: a hope from anti-inflammatory drugs? (2001) (2)
The role of the renin-angiotensin system in mediation of adrenal catecholamine secretion in the cat induced by intrarenal beta-adrenergic stimulation. (1980) (2)
Recent advances in the pharmacology of spinal cord injury (1993) (2)
Sodium and catecholamine excretion (1974) (2)
Effect of indomethacin on cardiac beta-adrenergic receptors. (1980) (2)
Substance K in Cardiovascular Control (1986) (2)
Immune tolerance and stroke: a turning point. (2002) (2)
Dermorphin: autonomic pharmacology and structure-activity relationships. (1986) (2)
Cardioprotection and Thrombolysis by Anistreplase in Anesthetized Dogs (1995) (2)
Prostaglandin Derivative PGBX Improves Neurologic Recovery After Ischemic Spinal Injury (1987) (2)
Binding of Fluorinated Analogues of Thyrotropin‐Releasing Hormone to TRH Receptors in the Rat Brain (1989) (2)
Cardiovascular and sympathetic effects of leukotriene D4 in renovascular and spontaneously hypertensive rats. (1984) (2)
Deteriorating stroke model (1987) (2)
Dermorphin tetrapeptide analog induces naloxonazine-reversible respiratory stimulation. (1990) (1)
Focus on Carvedilol for Heart Failure (1999) (1)
THE NOVEL P-SELECTIN INHIBITOR, PSI-697, REDUCES THROMBUS FORMATION IN AN EX-VIVO CLINICAL MODEL OF THROMBOSIS (2009) (1)
Evidence for the involvement of carbohydrate moieties in the adhesion of U937 cells to tumor necrosis factor-alpha (TNFalpha)-stimulated vascular endothelium in vitro. (1991) (1)
A biomarker of inflammation in cardiovascular disease (2003) (1)
Chemokines and Chemokine Receptors in the Central Nervous System: New Opportunities for Novel Therapeutics in Brain Ischemia and Trauma (2002) (1)
Respiratory Effects of TRH in Conscious Unrestrained Rats (1989) (1)
Respiratory Effects of TRH in Conscious Unrestrained Rats.: Use of a New Noninvasive Technique (1989) (1)
HUMORAL KIDNEY MEDIATION OF ADRENAL CATECHOLAMINE RESPONSE TO HEMORRHAGE (1977) (1)
Opportunities posed by novel patient selection biomarker approaches in oncology drug development: going beyond the cytotoxics. (2008) (1)
The Effect of Cold or Isolation Stress on Neuroinvasiveness and Neurovirulence of an Avirulent Variant of West Nile Virus (WN-25) (1991) (1)
Peripheral pressor effects of sympathetic stimulation, noradrenaline, angiotensin II and vasopressin in Brattleboro rats (1984) (1)
Cardiovascular and sympathetic responses to PGF2 alpha injection into hypothalamic nuclei. (1981) (1)
Catheterization of the Renal Artery for in vivo Infusion of the Kidney in the Cat (1978) (1)
Pharmacodynamic Studies of Fluorescent Diamond Carriers of Doxorubicin in Liver Cancer Cells and Colorectal Cancer Organoids (2021) (1)
Monthly Update: Vascular restenosis: A disease in search of therapy: Cardiovascular & Renal (1995) (1)
Strategic Concepts in Translational Medicine (2008) (1)
Dehydroepiandrosterone protects stressed mice from encephalitis by the attenuated west‐nile virus (1992) (1)
Author and Subject Index (1998) (1)
Congestive Heart Failure and Genomic Medicine: A Look into the 21st Century (1997) (1)
Editorial overviewPharmaceutical biotechnology (2004) (1)
Imaging of CNS Systems: Importance for Drug Development (2010) (1)
Fifty years of Biochemical Pharmacology: the discipline and the journal. (2008) (1)
PAF and TNF alpha interactions in the pathophysiology of septic shock. (1991) (1)
Mechanisms Involved in the Cardiac Protection Efficacy of Carvedilol (1999) (1)
Cardioprotective effects of carvedilol in anesthetized Yucatan minipigs (1992) (1)
Cerebrovascular Disease: Inflammation and stroke: benefits or harm? (2002) (1)
Protein kinase C activator phorbol 12, 13-dibutyrate inhibits platelet activating factor-stimulated Ca2+ mobilization and phosphoinositide turnover in neurohybrid NG108-15 cells (1992) (1)
Rosiglitazone improves the natriuretic response to atrial natriuretic peptide in rats with experimental congestive heart failure: possible involvement of a post-guanylate cyclase mechanism (2011) (0)
Mechanisms of Circulatory Collapse Induced by PAF-Acether (1987) (0)
Role of Inflammation in Stroke: Benefits or Harm? (2001) (0)
PLATELET ACTIVATING FACTOR (I-O-HEXADECYL-Z-ACETYL-SN- - GLYCERO-3-PHOSPHOCHOLINE)-IN SHR AND WCY RATS (1985) (0)
Catecholamines in Septic Shock: A Meta-Analysis Evaluation (2019) (0)
Effects of trichothecene mycotoxins on the nervous system (2017) (0)
Imaging and molecular biomarkers of vulnerable atheromatous plaques. (2007) (0)
Platelet-Activating Factor (PAF) Receptor in Brain and Signal Transduction in Neurons (1991) (0)
Platelet-Activating Factor in Sepsis: An Update (2020) (0)
Prostaglandin and Thromboxane Production in Postischemic Gerbil Brain (1987) (0)
Cornea Farinata and other Variants (2009) (0)
Interleukin-1/3 mRNA Expression inIschemic RatCortex (2011) (0)
Thyrotropin‐Releasing Hormone‐induced Hindquarter Vasodilation Is Mediated by β2‐Adrenoceptors (1989) (0)
Eprosartan reduces cardiomyopathy, improves ultrasound and MRI indices of cardiac function, improves renal function and eliminates mortality in stoke-prone rats (1999) (0)
227; IL‐2-INDUCED LUNG INJURY: MEDIATION BY LOCALLY PRODUCED TNFα (1994) (0)
Effects of Fluorescent Diamond Particles FDP-NV-800nm on Essential Biochemical Functions of Primary Human Umbilical Vein Cells and Human Hepatic Cell Line, HepG-2 in vitro (Part VI): Acute Biocompatibility Studies (2020) (0)
New opportunities for heart disease therapeutics (2000) (0)
EFFECT OF LXR-623, ALONE OR IN COMBINATION WITH SIMVASTATIN, ON REGRESSION AND STABILIZATION OF ATHEROSCLEROTIC PLAQUES: AN MRI STUDY IN A MODEL OF ADVANCED ATHEROSCLEROSIS (2010) (0)
Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques (1991) (0)
The use of differential display rt-PCR for identifying altered gene expression in ischemic brain injury. (1999) (0)
The use of differential display to demonstrate enhanced expression of protein kinase C14-3 3-gamma mRNA following rat carotid artery balloon angioplasty (1994) (0)
A Mitogen and Chemoattractant for Vascular Smooth Muscle Cells (2005) (0)
A Goldfish ModeJ for Evaluation of the Neurotaxicity of w-Conotoxin GVI A and Screening of Monoclonal Antibodies 0 (2011) (0)
EICOSANOIDS. PEPTIDES AND AMINES AND THE CEREBRAL BLOOD VESSELS (1990) (0)
Leukotriene D4 reduces pressor responses to sympathetic stimulation, angiotensin, and vasopressin. (1985) (0)
Treatment of Central Nervous System (CNS) Ischemia with a Prostaglandin Derivative, PGBx. (1986) (0)
Thrombosomes Show Dose-Dependent Increase in Thrombus Formation in a Model of Deep Arterial Injury (2011) (0)
The Pharmaceutical Industry Perspective (2009) (0)
Vol. 58, 1999 (1999) (0)
Future directions and perspectives for therapies based on the NPY family of peptides (2006) (0)
Abstract WP56: Imaging Intra-Carotid Thrombosis Using Near InfraRed Fluorescent-NanoDiamond Particles Bio-engineered With the Disintegrin Bitistatin (2018) (0)
Monthly Update Cardiovascular & Renal: Apoptosis in cardiac health and disease (1996) (0)
Experimental Heart Failure Effects of Eprosartan on Renal Function and Cardiac Hypertrophy in Rats With (1998) (0)
Inhibition of migration and proliferation of smooth muscle cells with hydroxycarbazole compounds. (1994) (0)
Nicardipine blocks deleterious cardiac effects of endothelinin vivo (1990) (0)
Hemodynamic defense response to trh injected into medial preoptic nucleus in rats (1991) (0)
Chemokines and chemokine receptors in the central nervous system: New opportunities for novel therapeutics in brain ischemia and trauma : Adenosine-based approaches to the treatment of neurodenegerative disease (2002) (0)
Comprehensive Assessment of Rosiglitazone on Cardiac Safety in a Rat Model of Heart Failure (2009) (0)
Clinical validity of blood and urinary desmosine as biomarkers for chronic obstructive pulmonary disease (2011) (0)
APPLICATION OF DIFFERENTIAL DISPLAY TECHNIQUE TO SEARCH FOR NEW GENES IN A RAT MODEL OF INTERLEUKIN‐2‐INDUCED LUNG INJURY.: 156 (1995) (0)
Viruses and Stress (2007) (0)
Acute T-2 Intoxication: Physiologic Consequences and New Therapeutic Approaches. (1992) (0)
074 In vivo cell tracking of superparamagnetic iron oxide-labelled mononuclear cells in humans (2010) (0)
Future directions and therapeutic perspectives for NPY/PYYbased anti-inflammatory and tumor suppressor drugs (2005) (0)
Carvedilol : Preclinical profile and rationale for its use in hypertension, coronary syndromes, and congestive heart failure (1996) (0)
The Role of Translational Medicine and Predictive Biomarkers in the Development of Novel, Innovative Treatments for the Management of Chronic Heart Failure: A Pharmaceutical Industry Perspective (2010) (0)
SB 211475, A METABOLITE OF CARVEDILOL, A NOVEL ANTIHYPERTENSIVE AGENT, EXERTS AN ANTI-SHOCK AND ENDOTHELIAL PROTECTIVE EFFECT IN RAT SPLANCHNIC ISCHEMIA AND REPERFUSION (1995) (0)
Effect of Thyrotropin-Releasing Hormone on Lipoxygenase-Induced Hypotension in the Unanesthetized Guinea Pig (1984) (0)
Nitric oxide, nitric oxide synthases and cyclooxygenase-2 in experimental focal stroke (2001) (0)
Systemic Effects Of Thromboxanes Released By Positive Endexpiratory Pressure (1981) (0)
Lipid peroxides and the coronary circulation. (1987) (0)
Application of High Resolution Cardiac Magnetic Resonance Imaging to Monitor a Rodent Model of Cardiac Dysfunction (2007) (0)
CARVEDILOL, A NEW &bgr;‐BLOCKER, VASODILATOR AND FREE RADICAL SCAVENGER, EXERTS PROTECTIVE EFFECTS IN RAT SPLANCHNIC ISCHEMIA AND REPERFUSION.: 45 (1995) (0)
IMMUNE CONSEQUENCES FOLLOWING ADMINISTRATION OF THE EXPERIMENTAL RED CELL SUBSTITUTE: LIPOSOME ENCAPSULATED HEMOGLOBIN (1995) (0)
Monthly Update: Cardiovascular & Renal: Sotalol and d-sotalol: Apparent benefits of beta-blocking activity for ventricular arrhythmias (1996) (0)
The Role of the Renin‐Angiotensin System in Mediation of Adrenal Catecholamine Secretion in the Cat Induced by Intrarenal β‐Adrenergic Stimulation (1980) (0)
N‐Ac‐Leukotriene E4 Unique Vascular Activity in the Conscious Rat (1988) (0)
Monocyte Chemoattractant Protein-1 is Upregulated in Rats With Volume-Overload (2000) (0)
NPY family of peptides in neurobiology, cardiovascular system and metabolism: genes, diseases and therapeutics (2006) (0)
Simvastatin reduces losartan‐induced nitric oxide production in spontaneously hypertensive rats (SHR) (2006) (0)
Evidence for the involvement of carbohydrate moieties in the adhesion of U937 cells to tumor necrosis factor-α (TNFα)-stimulated vascular endotheliumin vitro (1991) (0)
Monoclonal antibody reverses intracellular toxicity of the trichothecene mycotoxin t 2 (1987) (0)
Mesenteric vascular responses to i.v. administration and lipoxin B4 in the conscious rat of lipoxin A4 (1988) (0)
The role of lipid mediators in hypoxic pulmonary vasoconstriction in newborns. (1989) (0)
Pharmacology in cerebrovascular disease research: Pharmacokinetics–pharmacodynamics to the rescue (2016) (0)
mob‐1 EXPRESSION IN IL‐2‐INDUCED ARDS.: 178 (1996) (0)
Recent Observations With b -Adrenoceptor Blockade Beneﬁcial Effects in Hypertension and Heart Failure (1998) (0)
Cytokines in Endothelial Cell Survival and Apoptosis: A Role for Protein Kinases and Caspases (2002) (0)
Translational Medicine – A Paradigm Shift in Modern Drug Discovery and Development (2020) (0)
Pharmaceutical biotechnology. (2004) (0)
Selective hippocampal lesion following omega-conotoxin administration in rats. (1990) (0)
Neuropeptides: Evidence for Central Pathways and Role in Cardiovascular Regulation (2020) (0)
Subject Index Vol. 58, 1999 (1999) (0)
Leukotriene D4: divergent cardiovascular and sympathetic effects in spontaneously hypertensive and normotensive Wistar-Kyoto rats. (1983) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Giora G. Z. Feuerstein?

Giora G. Z. Feuerstein is affiliated with the following schools:

Giora G. Z. Feuerstein's Academic­Influence.com Rankings

Giora G. Z. Feuerstein's Degrees

Why Is Giora G. Z. Feuerstein Influential?

Giora G. Z. Feuerstein's Published Works

Published Works

What Schools Are Affiliated With Giora G. Z. Feuerstein?

Giora G. Z. Feuerstein's AcademicInfluence.com Rankings